Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting insulin-like growth factor signaling: rational combination strategies.

× No keyword cloud information.

13 in total

Review 1. Succinate dehydrogenase-deficient gastrointestinal stromal tumors.

Authors: Ya-Mei Wang; Meng-Li Gu; Feng Ji
Journal: World J Gastroenterol Date: 2015-02-28 Impact factor: 5.742

Review 2. The insulin and insulin-like growth factor receptor family in neoplasia: an update.

Authors: Michael Pollak
Journal: Nat Rev Cancer Date: 2012-02-16 Impact factor: 60.716

3. Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition.

Authors: Aleksandra Bielen; Gary Box; Lara Perryman; Lynn Bjerke; Sergey Popov; Yann Jamin; Alexa Jury; Melanie Valenti; Alexis de Haven Brandon; Vanessa Martins; Vincent Romanet; Sebastien Jeay; Florence I Raynaud; Francesco Hofmann; Simon P Robinson; Suzanne A Eccles; Chris Jones
Journal: Proc Natl Acad Sci U S A Date: 2012-04-23 Impact factor: 11.205

4. IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.

Authors: Salah-Eddine Lamhamedi-Cherradi; Brian A Menegaz; Vandhana Ramamoorthy; Deeksha Vishwamitra; Ying Wang; Rebecca L Maywald; Adriana S Buford; Izabela Fokt; Stanislaw Skora; Jing Wang; Aung Naing; Alexander J Lazar; Eric M Rohren; Najat C Daw; Vivek Subbiah; Robert S Benjamin; Ravin Ratan; Waldemar Priebe; Antonios G Mikos; Hesham M Amin; Joseph A Ludwig
Journal: J Natl Cancer Inst Date: 2016-08-30 Impact factor: 13.506

5. Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma.

Authors: Z Kang; Y Yu; Y J Zhu; S Davis; R Walker; P S Meltzer; L J Helman; L Cao
Journal: Oncogene Date: 2013-12-02 Impact factor: 9.867

6. Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways.

Authors: Cemal Erdem; Alison M Nagle; Angelo J Casa; Beate C Litzenburger; Yu-Fen Wang; D Lansing Taylor; Adrian V Lee; Timothy R Lezon
Journal: Mol Cell Proteomics Date: 2016-06-30 Impact factor: 5.911

Targeting insulin-like growth factor signaling: rational combination strategies.

Review 1. Succinate dehydrogenase-deficient gastrointestinal stromal tumors.

Review 2. The insulin and insulin-like growth factor receptor family in neoplasia: an update.

3. Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition.

4. IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.

5. Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma.

6. Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways.

Review 7. Impact of targeting insulin-like growth factor signaling in head and neck cancers.

Review 8. Clinical development of insulin-like growth factor receptor--1 (IGF-1R) inhibitors: at the crossroad?

9. Targeting IGF-1R: throwing out the baby with the bathwater?

10. Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives.